Okabe, M., Miyabe, S., Nagatsuka, H., Terada, A., Hanai, N., Yokoi, M., . . . Inagaki, H. (2006). MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma. Clinical cancer research, 12(13), 3902-3907. https://doi.org/10.1158/1078-0432.CCR-05-2376
Chicago Style (17th ed.) CitationOkabe, Mitsukuni, et al. "MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma." Clinical Cancer Research 12, no. 13 (2006): 3902-3907. https://doi.org/10.1158/1078-0432.CCR-05-2376.
MLA (9th ed.) CitationOkabe, Mitsukuni, et al. "MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma." Clinical Cancer Research, vol. 12, no. 13, 2006, pp. 3902-3907, https://doi.org/10.1158/1078-0432.CCR-05-2376.
Warning: These citations may not always be 100% accurate.